- Author
- Laura Wayteck (UGent) , Karine Breckpot, Jo Demeester (UGent) , Stefaan De Smedt (UGent) and Koen Raemdonck (UGent)
- Organization
- Keywords
- Predictive biomarkers, Tumor heterogeneity, Tumor antigens, Cancer immunotherapy, Personalized medicine, Adoptive T cell therapy, CD8(+) T-CELLS, CHIMERIC-ANTIGEN-RECEPTOR, ACUTE MYELOID-LEUKEMIA, IMMUNOSTIMULATORY MONOCLONAL-ANTIBODIES, TUMOR-INFILTRATING LYMPHOCYTES, EPITHELIAL OVARIAN-CANCER, METASTATIC MELANOMA, MESSENGER-RNA, DENDRITIC CELLS, CANCER/TESTIS ANTIGENS
Downloads
-
apersonalized.pdf
- full text
- |
- open access
- |
- |
- 751.86 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-5870003
- MLA
- Wayteck, Laura, et al. “A Personalized View on Cancer Immunotherapy.” CANCER LETTERS, vol. 352, no. 1, 2014, pp. 113–25, doi:10.1016/j.canlet.2013.09.016.
- APA
- Wayteck, L., Breckpot, K., Demeester, J., De Smedt, S., & Raemdonck, K. (2014). A personalized view on cancer immunotherapy. CANCER LETTERS, 352(1), 113–125. https://doi.org/10.1016/j.canlet.2013.09.016
- Chicago author-date
- Wayteck, Laura, Karine Breckpot, Jo Demeester, Stefaan De Smedt, and Koen Raemdonck. 2014. “A Personalized View on Cancer Immunotherapy.” CANCER LETTERS 352 (1): 113–25. https://doi.org/10.1016/j.canlet.2013.09.016.
- Chicago author-date (all authors)
- Wayteck, Laura, Karine Breckpot, Jo Demeester, Stefaan De Smedt, and Koen Raemdonck. 2014. “A Personalized View on Cancer Immunotherapy.” CANCER LETTERS 352 (1): 113–125. doi:10.1016/j.canlet.2013.09.016.
- Vancouver
- 1.Wayteck L, Breckpot K, Demeester J, De Smedt S, Raemdonck K. A personalized view on cancer immunotherapy. CANCER LETTERS. 2014;352(1):113–25.
- IEEE
- [1]L. Wayteck, K. Breckpot, J. Demeester, S. De Smedt, and K. Raemdonck, “A personalized view on cancer immunotherapy,” CANCER LETTERS, vol. 352, no. 1, pp. 113–125, 2014.
@article{5870003, author = {{Wayteck, Laura and Breckpot, Karine and Demeester, Jo and De Smedt, Stefaan and Raemdonck, Koen}}, issn = {{0304-3835}}, journal = {{CANCER LETTERS}}, keywords = {{Predictive biomarkers,Tumor heterogeneity,Tumor antigens,Cancer immunotherapy,Personalized medicine,Adoptive T cell therapy,CD8(+) T-CELLS,CHIMERIC-ANTIGEN-RECEPTOR,ACUTE MYELOID-LEUKEMIA,IMMUNOSTIMULATORY MONOCLONAL-ANTIBODIES,TUMOR-INFILTRATING LYMPHOCYTES,EPITHELIAL OVARIAN-CANCER,METASTATIC MELANOMA,MESSENGER-RNA,DENDRITIC CELLS,CANCER/TESTIS ANTIGENS}}, language = {{eng}}, number = {{1}}, pages = {{113--125}}, title = {{A personalized view on cancer immunotherapy}}, url = {{http://doi.org/10.1016/j.canlet.2013.09.016}}, volume = {{352}}, year = {{2014}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: